Alpa Thobhani

Statistics

Publications

Citations

2.3K

H-Index

Active since

2017

Affiliations

Georgetown Lombardi Comprehensive Cancer Center(Current)

Beth Israel Deaconess Medical Center

Memorial Sloan Kettering Cancer Center

Roche (United Kingdom)

Institut Gustave Roussy

Alpa Thobhani is an author at Georgetown Lombardi Comprehensive Cancer Center specializing in renal cell carcinoma, oncology, and atezolizumab therapy.

Publications per year

2017–2019

Publications

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F. McDermott, Mahrukh Huseni, Michael B. Atkins et al. · Nature Medicine · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Brian I. Rini, Thomas Powles, Michael B. Atkins et al. · The Lancet · 2019 · 1K citations

Medicine, Oncology, Pharmacology +13

IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)

Thomas Powles, David F. McDermott, Brian I. Rini et al. · Annals of Oncology · 2017 · 20 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3